医学
门静脉压
门脉高压
内科学
前瞻性队列研究
压力梯度
静脉压
相关性
放射科
血压
肝硬化
物理
机械
几何学
数学
作者
Belén Martínez‐Moreno,Juan Martínez Martínez,Iván Herrera,Lucía Guilabert,Maria M. Rodríguez,Pablo Bellot,Cayetano Miralles,Sonia Pascual,Javier Irurzun,Pedro Zapater,José María Palazón-Azorín,Vicente Gil-Guillén,Rodrigo Jover,José Ramón Aparicio
出处
期刊:Endoscopy
[Thieme Medical Publishers (Germany)]
日期:2024-07-18
卷期号:57 (01): 62-67
被引量:32
摘要
BACKGROUND: Hepatic venous portal gradient (HVPG) measurement remains the gold standard for estimating portal pressure gradient (PPG). This study aimed to evaluate the correlation between endoscopic ultrasound (EUS)-guided PPG and HVPG in patients with chronic portal hypertension. METHODS: Patients with chronic portal hypertension in whom HVPG assessment was clinically indicated were invited to undergo transjugular HVPG and EUS-PPG with a 22-G needle in separate sessions for comparison. Intraclass correlation coefficient (ICC) and the Bland-Altman method were used to evaluate the agreement between techniques. RESULTS: 33 patients were included. No significant differences in technical success were observed: EUS-PPG (31/33, 93.9%) vs. HVPG (31/33, 93.9%). Overall, 30 patients who underwent successful EUS-PPG and HVPG were analyzed. Correlation between the two techniques showed an ICC of 0.82 (0.65-0.91). Four patients had major discrepancies (≥5 mmHg) between HVPG and EUS-PPG. No significant differences in adverse events were observed. CONCLUSIONS: The correlation between EUS-PPG and HVPG was almost perfect. EUS-PPG could be a safe and reliable method for direct PPG measurement in patients with cirrhosis and a valid alternative to HVPG.
科研通智能强力驱动
Strongly Powered by AbleSci AI